1 / 7

Systemic Lupus Erythematosus Treatment Market: Size & Share - Industry Trend and Forecast 2019 - 2027

Systemic Lupus Erythematosus Treatment Market is driven by increase in number of systemic lupus erythematosus (SLE) patients. Global market is projected to grow at a CAGR of ~7%, and reach a valuation of ~US$ 3 Bn by the year 2027.

pharmahealth
Download Presentation

Systemic Lupus Erythematosus Treatment Market: Size & Share - Industry Trend and Forecast 2019 - 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ©2019 Transparency Market Research, All Rights Reserved Systemic Lupus Erythematosus Treatment Market Drug: Antimalarial Drugs, Non-steroidal Anti- inflammatory Drugs , Corticosteroids, Immunosuppressive Drugs; Mode of Delivery: Intravenous, Subcutaneous, and Oral; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Sales - Forecast 2019 - 2027 ©2019 Transparency Market Research, All Rights Reserved

  2. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Market Outlook Chapter 6 Global Systemic Lupus Erythematosus Treatment Market Analysis, by Drug Chapter 7 Global Systemic Lupus Erythematosus Treatment Market Analysis, by Mode of Delivery Chapter 8 Global Systemic Lupus Erythematosus Treatment Market Analysis, by Region Chapter 9 North America Systemic Lupus Erythematosus Treatment Market Analysis Chapter 10 Europe Systemic Lupus Erythematosus Treatment Market Analysis Chapter 11 Asia Pacific Systemic Lupus Erythematosus Treatment Market Analysis Chapter 12 Latin America Systemic Lupus Erythematosus Treatment Market Analysis Chapter 13 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Analysis Chapter 14 Competition Landscape

  3. ©2019 Transparency Market Research, All Rights Reserved Systemic Lupus Erythematosus Treatment Market: Snapshot • Systemic Lupus Erythematosus (SLE) is a prototypic multisystem autoimmune disorder with a broad spectrum of clinical presentations, encompassing almost all organs and tissues. It can affect the skin, joints, kidneys, brain, and other organs. • Increase in number of systemic lupus erythematosus (SLE) patients has resulted in growth of the global systemic lupus erythematosus treatment market. • Global systemic lupus erythematosus treatment market has been segmented into hospital pharmacies, retail pharmacies, and online sales. ©2019 Transparency Market Research, All Rights Reserved

  4. ©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved

  5. ©2019 Transparency Market Research, All Rights Reserved Reports Highlights • Global systemic lupus erythematosus treatment market was valued at ~US$ 1.7 Bn in 2018, and is projected to expand at a CAGR of ~7% from 2019 to 2027. • Key players operating in the global systemic lupus erythematosus treatment market are GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Bristol-Myers Squibb Company, Anthera Pharmaceuticals, Inc., ImmuPharma PLC, and Aurinia Pharmaceuticals, Inc. ©2019 Transparency Market Research, All Rights Reserved Request Sample

  6. ©2019 Transparency Market Research, All Rights Reserved Continue.. • In September, 2017, Amgen Inc. And ALLERGAN Collectively Obtained FDA Approval For The Use Of MVASI To Treat Five Types Of Cancer. • Continuous Launch Of New Products And Increase In The Number Of Patients In DevelopedAnd Developing Countries. • Expansion Of Drugs Delivery System Portfolio: By Improving Existing Drug Delivery Devices And Developing And Launching Of New Drug Delivery System Through Collaboration. ©2019 Transparency Market Research, All Rights Reserved Request Brochure

  7. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U

More Related